Lobbying Filing Details

Total Spending

$50,000

Activities

2

Lobbyists

3

Gov't Entities

4

Filing Information
Filing UUID:
b220f3f5-0831-427f-910e-fd6267185d9c
Type:
2A - 2nd Quarter - Amendment
Period:
2024 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 18, 2024 at 7:56 PM
Income:
$50,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Jay B. Stewart
Registrant
HANCE SCARBOROUGH

Law Firm

Washington, District of Columbia
Client
ALLIANCE FOR PHARMACY COMPOUNDING

Non-profit association promoting the practice of pharmacy compounding

Texas, United States of America
Lobbying Activities (2)
Activity 1
Health Issues

Issues related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations HR167, the Patient Access to Urgent Use Compounded Medication Act

Lobbyists (3)
  • MICHAEL TOMBERLIN
  • THERESA REED
  • MR. ROBERT DAVID PORE
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 2
Pharmacy

Issues related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations HR167, the Patient Access to Urgent Use Compounded Medication Act

Lobbyists (3)
  • MICHAEL TOMBERLIN
  • THERESA REED
  • MR. ROBERT DAVID PORE
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 4, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.